Closed · W81XWH-22-ARP-IDA · CFDA 12.420 · Discretionary
DOD, Autism Research Program, Idea Development Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- August 18, 2022
- Close date
- 4
- Expected awards
The verdict
DOD, Autism Research Program, Idea Development Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 4 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 4
- expected awards
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DOD, Autism Research Program, Idea Development Award - is cataloged under number W81XWH-22-ARP-IDA and tied to CFDA assistance listing 12.420, posted by Defense Health Agency Contracting Activity - DHACA. Grants.gov currently shows the opportunity as closed, first posted on March 29, 2022. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. The agency has projected $3.5 million in total estimated funding for this announcement. It expects to issue 4 awards. If the agency funds the expected 4 awards from the $3.5 million estimated pool, the average award works out to roughly $880,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on August 18, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
August 18, 2022
Posted
March 29, 2022
Est. Total Funding
$3,520,000
Expected Awards
4
Instrument
Grant
Description
The FY22 ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD. Applications are strongly encouraged to address one of the FY22 ARP Career Development Award Areas of Interest or provide justification that the proposed research addresses a critical problem, question, or need in ASD. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation.Important aspects of the FY22 ARP Idea Development Award are as follows:• Impact: The proposed research is expected to make an important and original contribution to advancing the understanding of ASD and ultimately lead to improved outcomes for individuals with ASD and their families/caregivers. The project’s impact on both ASD research and ASD care should be articulated even if clinical impact is not an immediate outcome. A statistical plan is an important aspect of the FY22 ARP Idea Development Award to demonstrate the significance of any research outcomes or findings.• Innovation: Research deemed innovative may represent a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research may be innovative in study concept, research methods or technology, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative.• Personnel: Personnel are considered a crucial element of the FY22 ARP Idea Development Award. The study team should have experience in ASD research. Inclusion of a biostatistician in the study team is encouraged.• Research must be based on preliminary data: Although the proposed research must have direct relevance to ASD, the required preliminary data, which may include unpublished results from the laboratory of the Principal Investigators (PIs), research team, or collaborators named on the application, may be from outside the ASD research field. Research should also be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.Partnering PI Option: The FY22 ARP supports collaborative research to bring a new perspective to ASD research and/or facilitate progress in the field by combined efforts. Therefore, the ARP Idea Development Award mechanism includes a Partnering PI Option, which is structured so that two investigators, each of whom will be designated as a PI and receive a separate award, will work synergistically on a single project. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI will be identified as a Partnering PI. Both PIs should collaborate to develop a synergistic project addressing one or more of the FY22 ARP Idea Development Award Areas of Interest or another critical problem, question, or need in ASD. Applications submitted by a mentor and trainee as Initiating PI and Partnering PI do not meet the intent of the Partnering PI Option. Multidisciplinary and multi-organizational projects are allowed.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |